Major Pulmonary Surgery in Patients with Compromised Lung Function

Detalhes bibliográficos
Autor(a) principal: Gonçalves Pereira, R
Data de Publicação: 2021
Outros Autores: Branco, J, Narciso Rocha, F, Figueiredo, C, Costa, AR, Santos Silva, J, Eurico Reis, J, Calvinho, P
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.17/4419
Resumo: Introduction: The risk stratification of lung resection is fundamentally based on the results of pulmonary function tests. In patients considered to be at risk, major surgery is generally denied, opting for potentially less curative therapies. Objective: To evaluate the postoperative outcomes of major lung surgery in a group of patients deemed high risk. Methods: We performed a retrospective review of clinical records of all patients submitted to lobectomy, bilobectomy or pneumonectomy in a 3-year period in a reference Thoracic Surgery Unit. The patients were then divided in two groups: group A composed of patients with normal preoperative pulmonary function and group B which included patients with impaired lung function, defined as FEV1 and/or DLCO ≤60%. Results: A total of 234 patients were included, 181 (77.4%) in group A and 53 (22.6%) in group B. In group B, patients had more smoking habits, were more often associated with chronic obstructive pulmonary disease and were also more frequently submitted to thoracotomy. When surgery was motivated by primary lung cancer this group had a more advanced clinical stage of the disease. In the postoperative period, these patients had longer hospital stay, longer chest drainage time and greater need for oxygen therapy at home, however, no statistically significant difference was noted in morbidity or mortality. Conclusions: Major thoracic surgery can be safely performed in selected patients considered to be high risk for resection by pulmonary function tests. A potentially curative surgery should not be denied based on respiratory function tests alone.
id RCAP_e891975b6372213cdb53bfc702ed24b7
oai_identifier_str oai:repositorio.chlc.min-saude.pt:10400.17/4419
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Major Pulmonary Surgery in Patients with Compromised Lung FunctionHSM CCTHumansLung / surgeryLung Diseases* / surgeryPneumonectomy / adverse effectsPostoperative Complications* / epidemiologyRespiratory Function TestsIntroduction: The risk stratification of lung resection is fundamentally based on the results of pulmonary function tests. In patients considered to be at risk, major surgery is generally denied, opting for potentially less curative therapies. Objective: To evaluate the postoperative outcomes of major lung surgery in a group of patients deemed high risk. Methods: We performed a retrospective review of clinical records of all patients submitted to lobectomy, bilobectomy or pneumonectomy in a 3-year period in a reference Thoracic Surgery Unit. The patients were then divided in two groups: group A composed of patients with normal preoperative pulmonary function and group B which included patients with impaired lung function, defined as FEV1 and/or DLCO ≤60%. Results: A total of 234 patients were included, 181 (77.4%) in group A and 53 (22.6%) in group B. In group B, patients had more smoking habits, were more often associated with chronic obstructive pulmonary disease and were also more frequently submitted to thoracotomy. When surgery was motivated by primary lung cancer this group had a more advanced clinical stage of the disease. In the postoperative period, these patients had longer hospital stay, longer chest drainage time and greater need for oxygen therapy at home, however, no statistically significant difference was noted in morbidity or mortality. Conclusions: Major thoracic surgery can be safely performed in selected patients considered to be high risk for resection by pulmonary function tests. A potentially curative surgery should not be denied based on respiratory function tests alone.Sociedade Portuguesa de Cirurgia Cardio-Torácica e VascularRepositório do Centro Hospitalar Universitário de Lisboa Central, EPEGonçalves Pereira, RBranco, JNarciso Rocha, FFigueiredo, CCosta, ARSantos Silva, JEurico Reis, JCalvinho, P2023-02-22T15:14:25Z2021-112021-11-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.17/4419engPort J Card Thorac Vasc Surg . 2021 Nov 7;28(3):25-32.10.48729/pjctvs.191.info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-03-10T09:46:23Zoai:repositorio.chlc.min-saude.pt:10400.17/4419Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T17:21:46.328575Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Major Pulmonary Surgery in Patients with Compromised Lung Function
title Major Pulmonary Surgery in Patients with Compromised Lung Function
spellingShingle Major Pulmonary Surgery in Patients with Compromised Lung Function
Gonçalves Pereira, R
HSM CCT
Humans
Lung / surgery
Lung Diseases* / surgery
Pneumonectomy / adverse effects
Postoperative Complications* / epidemiology
Respiratory Function Tests
title_short Major Pulmonary Surgery in Patients with Compromised Lung Function
title_full Major Pulmonary Surgery in Patients with Compromised Lung Function
title_fullStr Major Pulmonary Surgery in Patients with Compromised Lung Function
title_full_unstemmed Major Pulmonary Surgery in Patients with Compromised Lung Function
title_sort Major Pulmonary Surgery in Patients with Compromised Lung Function
author Gonçalves Pereira, R
author_facet Gonçalves Pereira, R
Branco, J
Narciso Rocha, F
Figueiredo, C
Costa, AR
Santos Silva, J
Eurico Reis, J
Calvinho, P
author_role author
author2 Branco, J
Narciso Rocha, F
Figueiredo, C
Costa, AR
Santos Silva, J
Eurico Reis, J
Calvinho, P
author2_role author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório do Centro Hospitalar Universitário de Lisboa Central, EPE
dc.contributor.author.fl_str_mv Gonçalves Pereira, R
Branco, J
Narciso Rocha, F
Figueiredo, C
Costa, AR
Santos Silva, J
Eurico Reis, J
Calvinho, P
dc.subject.por.fl_str_mv HSM CCT
Humans
Lung / surgery
Lung Diseases* / surgery
Pneumonectomy / adverse effects
Postoperative Complications* / epidemiology
Respiratory Function Tests
topic HSM CCT
Humans
Lung / surgery
Lung Diseases* / surgery
Pneumonectomy / adverse effects
Postoperative Complications* / epidemiology
Respiratory Function Tests
description Introduction: The risk stratification of lung resection is fundamentally based on the results of pulmonary function tests. In patients considered to be at risk, major surgery is generally denied, opting for potentially less curative therapies. Objective: To evaluate the postoperative outcomes of major lung surgery in a group of patients deemed high risk. Methods: We performed a retrospective review of clinical records of all patients submitted to lobectomy, bilobectomy or pneumonectomy in a 3-year period in a reference Thoracic Surgery Unit. The patients were then divided in two groups: group A composed of patients with normal preoperative pulmonary function and group B which included patients with impaired lung function, defined as FEV1 and/or DLCO ≤60%. Results: A total of 234 patients were included, 181 (77.4%) in group A and 53 (22.6%) in group B. In group B, patients had more smoking habits, were more often associated with chronic obstructive pulmonary disease and were also more frequently submitted to thoracotomy. When surgery was motivated by primary lung cancer this group had a more advanced clinical stage of the disease. In the postoperative period, these patients had longer hospital stay, longer chest drainage time and greater need for oxygen therapy at home, however, no statistically significant difference was noted in morbidity or mortality. Conclusions: Major thoracic surgery can be safely performed in selected patients considered to be high risk for resection by pulmonary function tests. A potentially curative surgery should not be denied based on respiratory function tests alone.
publishDate 2021
dc.date.none.fl_str_mv 2021-11
2021-11-01T00:00:00Z
2023-02-22T15:14:25Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.17/4419
url http://hdl.handle.net/10400.17/4419
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Port J Card Thorac Vasc Surg . 2021 Nov 7;28(3):25-32.
10.48729/pjctvs.191.
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Sociedade Portuguesa de Cirurgia Cardio-Torácica e Vascular
publisher.none.fl_str_mv Sociedade Portuguesa de Cirurgia Cardio-Torácica e Vascular
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799131312825565184